Explore

Trendline Trendline
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
Trendline Trendline
Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate
Trendline Trendline
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Trendline Trendline
Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development

Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development

Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Trendline Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion

Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion

Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Trendline Trendline
Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity

Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity

Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity
Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy

Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy

Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy
Trendline Trendline
Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline